Linkage studies in schizophrenia have identified a candidate region on chromosome 10p14-11 as reported for several independent samples. We investigated association of DNA sequence variants in a plausible candidate gene located in this region, the gene for phosphatidylinositol-4-phosphate 5-kinase IIa (PIP5K2A), in a sample of 65 sib-pair families for which linkage had been reported. Evidence for association was obtained for 15 polymorphisms spanning 73.6 kb in the genomic region of the gene between intron 4 and the 3 0 untranslated region, a region with high degree of linkage disequilibrium. Single nucleotide polymorphism (SNP) rs10828317 located in exon 7 and causing a non-synonymous amino-acid exchange (asparagine/serine) produced a P-value of 0.001 (experiment-wide significance level 0.00275) for over-transmission of the major allele coding for serine, analysed by transmission disequilibrium test using FAMHAP. Association of this SNP with schizophrenia has been also described in a sample of 273 Dutch schizophrenic patients and 580 controls (P = 0.0004). PIP5K2A is involved in the biosynthesis of phosphatidylinositol-4,5-bisphosphate (PI(4,5)P 2 ), one of the key metabolic crossroads in phosphoinositide signalling. PI(4,5)P 2 plays a role in membrane transduction of neurotransmitter signals as well as in intracellular signalling, pathways that may be impaired in schizophrenia.
Introduction
Schizophrenia is a devastating mental disorder with complex genetic background. 1 Susceptibility alleles, that is, alleles conferring risk for the disorder and having only a moderate effect on phenotype expression, are expected to contribute to the development of the disorder. This is in contrast to most monogenic disorders where causative DNA sequence variants (mutations) with usually larger effects are involved.
The lack of a one to one relationship between phenotype and genotype renders application of classical linkage analysis in complex disorders difficult. 2 Despite this constraint, a number of linkage studies have been performed in schizophrenia using parametric and non-parametric methods. 3 Statistical evidence for linkage has been reported for several regions, distributed over the whole genome. However, the majority of these linkage studies did not fulfil stringent criteria such as genome-wide significance, concentration of elevated LOD scores within a narrow defined peak and replication in independent family samples. Consequently, detecting linkage in schizophrenia cannot be taken as proof for existence of a susceptibility gene, but may be suggestive for regions that can be tested for the existence of candidate genes associated with the disorder.
DNA sequence variants in potential susceptibility genes associated with schizophrenia have been detected in some regions where evidence for linkage has been reported previously. On chromosome 8p22-21, [4] [5] [6] DNA sequence variants in the gene for neuregulin 1 have been found to be associated with schizophrenia as single markers and, in combination, as multilocus haplotypes. 7, 8 Association of single nucleotide polymorphisms (SNPs) in the genomic region of dystrobrevin binding protein 1 (dysbindin) located on chromosome 6p24-22, another region with evidence for linkage to schizophrenia, 4, [9] [10] [11] [12] [13] [14] [15] has been reported. [16] [17] [18] [19] [20] Further candidate genes identified in areas with reported linkage to schizophrenia include G72 on chromosome 13q32-q34, 21 RGS4, 22 Capon 23 and DISC1 24, 25 on chromosome 1q21-q22, TRAR4 on chromosome 6q13-q26 26 and Epsin 4 on chromosome 5q. 27 For most of these genes, a role in brain function has been proposed, 28 but DNA variants (mutations in coding or regulatory sequences) with impact on brain function and eventually leading to the development of schizophrenia have not been identified yet. Thus, some of the currently proposed susceptibility genes may turn out to be false positives, whereas others still remain to be discovered. The number of true susceptibility genes involved in development of schizophrenia cannot be estimated at the present stage.
Evidence from linkage analysis for a locus, conferring susceptibility to schizophrenia on chromosome 10p14-p11, has been reported by a number of studies. [29] [30] [31] [32] [33] [34] [35] [36] In addition, evidence for linkage to bipolar disorder has been reported in this region for the NIMH consortium bipolar sample. 30 The highest LOD scores obtained in these studies were concentrating around the microsatellite marker D10S1423 comprising a relatively small area. As parental genotype information is available in our sample with linkage, 37 we had been able to apply a transmission disequilibrium test modified for application to sib-pairs in order to test for association in the presence of linkage. 38 We tested all microsatellite markers from our genome-wide scan using the ASPEX program and obtained a nominally significant P-value of 0.038 for marker D10S211, 37 which is located in the linkage peak.
We searched databases for candidate genes in the vicinity of D10S211 and identified approximately 900 kb downstream the gene for the enzyme phosphatidylinositol-4-phosphate 5-kinase, type II, alpha (PIP5K2A) as a potential susceptibility gene for schizophrenia. The enzyme is involved in phosphoinositide signalling, predominantly catalysing phosphorylation of phosphatidylinositol-5-phosphate (PI(5)P) to phosphatidylinositol-4,5-bisphosphate (PI(4,5)P 2 ). [39] [40] [41] The latter compound plays a role in transmembrane transduction of neurotransmitter signals in connection with intracellular Ca 2 þ signalling as well as in a number of other intracellular signalling pathways. 39, 40 Based on these considerations, we decided to apply a combined positional/functional candidate gene approach and investigated association of DNA sequence variants in the region, where PIP5K2A is located, using the family sample where we had detected linkage. We detected several variants in linkage disequilibrium (LD) with schizophrenia in the genomic region of PIP5K2A. One of the variants, M41, that produced nominally significant P-values in this study is located in exon 7 of the gene and constitutes a non-synonymous amino-acid exchange N/S in position 251 of the protein. Over-transmission of the allele with major frequency coding for S was observed in our family sample.
Materials and methods

Families
The sib-pair sample consisted of 65 families with 141 affected offspring. Fifty-six families were from Germany and nine from Israel. The sample was taken from 71 families included in the linkage studies previously reported. 33, 37 For six families, the supply of DNA was not available in sufficient quantity for these studies. There were 57 families with affected sib pairs, six families with three affected, one with four and one with five. With the exception of three sib-pair families and one triplet with one parent, but with additional unaffected family members, DNA was available for both parents. All individuals had been interviewed with the Schedule for Affective Disorder Schizophrenia-Lifetime Version (SADS-L) or the Structured Clinical Interview for DSM-III-R Disorders (SCID-II). 42 Case records were evaluated by operational criteria checklist for psychotic illness (OPCRIT). 43 The complete interview form, family history information and the medical record of each individual were reviewed by an independent psychiatrist without prior knowledge of family relationship to the index patient or of morbidity in the family. The 141 affected offspring consisted of 121 individuals with a core diagnosis of schizophrenia (DSM-III-R) and 20 individuals with a diagnosis of schizoaffective disorder, schizophrenic subtype, according to the Research Diagnostic Criteria. 44 Written informed consent was obtained from all participants after a detailed description of the study, which was approved by the internal review boards of the University of Bonn, Germany; the HadassahHebrew University Medical Center, Israel; and the Mental State Hospital, Haar, Germany.
Genomic DNA DNA was isolated from whole blood or permanent cell lines derived from Epstein-Barr virus-transformed lymphocytes using a Qiagen Blood-and Cell-Culture kit according to the instructions of the manufacturer.
Identification of SNPs PCR primers were designed covering the 10 exons and adjacent intron sequences for amplification of 200-300 bp suitable for single-stranded conformation polymorphism (SSCP) analysis. 45 Briefly, PCR Microsatellites. Amplification of microsatellite loci was performed by PCR with fluorescence-labelled primers as described previously. 37 Fragment analysis was carried out by means of a DNA sequencer type 377 (Applied Biosystems, Forster City, CA, USA); genotypes were assigned using genotyping software Genescan 2.02 and Genotyper 1.1 (Applied Biosystems).
Fluorescence polarization detection of templatedirected dye-terminator incorporation. Fluorescence polarization detection of template-directed dyeterminator incorporation (FP-TDI) was performed essentially as described, 46 ,47 except using acyclodideoxynucleotides and AcycloPol polymerase as supplied in the AcycloPrime-FP-SNP-Detection kit (Perkin Elmer Life Sciences, Boston, MA, USA). Briefly, 12.5 ng genomic DNA was amplified by PCR using standard conditions and the remaining nucleotides and primers inactivated by incubation with shrimp alkaline phosphatase (SAP) and exonuclease 1 as supplied with the Cleanup Reagent (Perkin Elmer Life Sciences). Single base extension reaction was performed using the conditions as recommended by the supplier. Fluorescence polarization was measured using a Tecan 384 Ultra reader (Tecan US, Durham, NC, USA) and data analysed with the Easy SNP E 2.0 (Tecan) software.
Allele discrimination by matrix-assisted laser desorption/ionization time-of-flight analysis. Genotyping of SNPs by mass spectrometry was performed as described. 48 In brief, primers were designed by SpectroDESIGNER software (Sequenom, San Diego, CA, USA) and PCR carried out using AmpliTAQ Gold (0.1 U, Perkin Elmer, Boston, MA, USA) under standard conditions. The amplification products were treated with SAP and the MassEXTEND reactions performed as described. 48 Each reaction was loaded on 384-well SpectroCHIPs and analysed by a MassARRAY RT mass spectrometer (BrukerSequenom 49 ). The resulting spectra were analysed by SPECTROTYPER software (Sequenom).
Masscode SNP allele discrimination. High-throughput SNP genotyping with the Masscode System 50 was conducted at QIAGEN Genomics Inc., Bothell, WA, USA. The method is essentially an allele-specific PCR SNP discrimination assay using small-molecularweight tags covalently attached through a photocleavable linker to an oligonucleotide. After photolysis, the mass of the tags is analysed in a single quadrupole mass spectrometry detection system. Genotype determinations are based on the relative proportions of the paired allele tags and analysed by cluster plots.
Statistical tests
The program FAMHAP version 15 was used to estimate haplotype frequencies with the EM-algorithm. 51 The program with the 'zhao' option was also used to calculate unadjusted P-values for association of single markers and haplotypes with schizophrenia. Using this option, an association test based on MonteCarlo simulations is performed, in which the set of transmitted and non-transmitted genotypes is randomly permutated in each replication. 52 The test has been extended to test the null hypothesis of no association in samples of nuclear families with more than a single affected offspring, even in the presence of linkage. 53 P-values corrected for multiple testing were obtained as described. 54 FAMHAP also calculates LD measures D 055 for non-transmitted ('pseudo'-controls) and transmitted haplotypes separately. The spectral decomposition method 56, 57 was used to estimate the number of effective loci and to determine the experiment-wide significance threshold required to keep type I error rate at 5%.
Results
The genomic structure of the gene PIP5K2A was not known when the study commenced. Thus, we determined exon-intron boundaries by sequencing BACs (F-factor-based bacterial artificial chromosomes) from coding sequences into introns. BACs had been isolated before by screening the CTB library 58 with sequences from the published cDNA sequence. 59 The obtained information on the boundaries could be further confirmed when the human genome sequence became available. SSCP analysis of amplification products of exon and adjacent intron sequences revealed a number of sequence variations (Table 1) . Amplification products showing changes in SSCP analysis were sequenced in order to confirm and identify the position of the variation. We identified five polymorphisms, among them an A to G exchange in exon 7. This variant changes position two of the codon for N resulting in a non-synonymous amino-acid exchange with S in amino-acid position 251 of the protein. In addition, we identified two short tandem repeats (STRs) ( Table 1 ) by sequencing. These polymorphisms were supplemented with 24 SNPs selected from the dbSNP or from the Celera SNP database, as well as with four STRs (Table 1) , in order to cover the genomic sequence of the gene as well as 110.8 kb of the 5 0 untranslated region (UTR) (M21) and 114 kb of the 3 0 UTR (M52) ( Table 1) . We genotyped these polymorphisms in the sample of 65 families, where the linkage signal was obtained. 33 No deviation from Hardy-Weinberg equilibrium was detected for these markers in the parents. P-values were calculated from the differences between transmitted and non-transmitted alleles using the program FAMHAP 51, 54 with the 'zhao' option. All 65 families were included for haplotype frequency estimation, but for the subsequent testing method only fully typed families, that is, genotypes of both parents and siblings, were used (61 families) for calculation of P-values. The null hypothesis for this test is no association in the presence of linkage. 53 Fifteen DNA sequence variants located between exon 4 and the 3 0 UTR of the gene and spanning 73.6 kb ( Figure 1 and Table 1 ) produced nominally significant P-values. A P-value of 0.001 was obtained for SNP M41 (N251S) in exon seven. The value remained nominally significant after applying the spectral decomposition method, 56, 57 which reduced the number of effective markers to 21.38. Using this number, the experimentwide significance threshold was estimated to be 0.00275. Alleles with major allele frequencies were over-transmitted for all markers (Table 1 ). Table 1 also shows the transmission ratio T/NT for markers with P-values < 0.05. This value can be taken as an estimator for the relative risk under a multiplicative model. 60 Accordingly, a relative risk of 1.92 was estimated for exonic polymorphism M41 (Table 1) .
Intermarker LD for SNPs in the region between M28 and M51 was calculated using the frequency of the non-transmitted alleles as (pseudo-) controls (Table 2 below diagonal). The area between exon 5 (M38) and the 3 0 UTR (M51) exhibits extensive LD and appears to form a haplotype block (Table 2) . Recombination hot spots occur at marker M37 as well as at markers M32 and M33. The pattern for the transmitted allele ('cases'; Table 2 Figure 1) .
We calculated all possible two-and three-locus haplotypes and estimated the transmission to affected offspring in comparison to non-transmitted haplotypes. P-values for haplotypes did not improve over the values for single markers, which could be explained by the high degree of LD in the area, and yielded therefore no additional information on the possible location of a susceptibility allele (data not shown). We also constructed multilocus haplotypes composed of 12 SNPs (M39-M51) located between intron 6 and the 3 0 UTR (Figure 1 ) spanning 42.9 kb. Transmission of 65 alleles from heterozygous parents was counted for the haplotype with highest frequency (H1; Table 3 ) as opposed to 37 non-transmitted alleles (P = 0.005 uncorrected, P = 0.037 after Bonferroni correction for seven haplotypes). This haplotype is composed entirely of alleles with major allele frequency. We tested additional SNPs and microsatellite markers centromeric of the gene (Table 1, M1-M22) , covering the promoter region (the gene is on the reversed strand) and extending to regions where according to the UCSC database additional genes are located. A higher marker density was chosen for MSRB2 (methionine sulphoxide reductase B2, also known as PILB), because of its possible role as a transcription factor. With the exception of a weak nominally significant P-value (0.015) for the microsatellite marker D10S1660 (M15; Table 1), no further evidence of association was observed for variants within the genomic region of this gene. However, SNP M20 (125 kb distal to exon 1 of MSRB2/PILB) displayed a nominally significant value of P = 0.0009 (Table 1) . As it has been reported that LD can extend over considerable distances, 61 we tested two and three marker haplotypes composed of M20 and markers M39, M41 (exonic variant) and M43 for association with schizophrenia. These SNPs are located in the centre of the associated region and showed nominally significant P-values as single markers ( Figure 1 and Table 1 ). Significant P-values were produced for twolocus haplotypes composed of M20, M39, M41 and M43 (Table 4 ). In contrast, haplotypes composed of M21, which did not show association as single marker, did not produce significant P-values for association with schizophrenia (Table 4 ). In addition, we calculated pairwise intermarker LD between M20 and M39, M41 and M43, as well as between M21 and three SNPs. D 0 values around 0.5 were obtained between M20 and the three SNPs in the PIP5K2A gene using the non-transmitted alleles as (pseudo-) controls. Conversely, no LD was observed between M21 and the three SNPs. This suggests that SNP M20 is in long-range LD with the haplotype block ( Table 4 ) that contains the schizophreniaassociated variants.
Discussion
Our study suggests potential involvement of PIP5K2A in the development of schizophrenia:
1. The gene is located in an area where linkage with schizophrenia has been reported independently in several family samples.
29-36
Figure 1 Genomic structure of PIP5K2A and position of DNA sequence variants. Location of variants is indicated by arrows. The length of the arrows corresponds to P-values. The order of the marker is the same as in Table 1 . The gene maps at chromosome 10p12.32 on the reverse strand. Additional evidence comes from an independent study following our preliminary reports communicated at the IXth and XIth World Congress for Psychiatric Genetics. 63, 64 Bakker and co-workers 65 obtained nominally significant association (P = 0.0004) with the exonic SNP rs10828317 (M41, N251S) in a sample of 273 Dutch schizophrenia patients and 580 controls. In both studies, the same allele (A) was found to be associated with schizophrenia.
PIP5K2A was originally reported to phosphorylate PI(4)P to PI(4,5)P 2 . 59 Later, it has been shown that the enzyme catalyses preferentially phosphorylation of PI(5)P in the 4th position to PI(4,5)P 2 . 41 PI(4,5)P 2 plays a key role in phosphoinositide signalling pathways. Upon activation by G-proteins, PI(4,5)P 2 is cleaved by the action of phospholipase C into inositoltrisphosphate (IP3) and diacylglycerol. IP3 activates release of Ca 2 þ from intracellular sequestering compartments, whereas diacylglycerol activates kinase C, which is involved in intracellular regulatory processes via protein phosphorylation. A number of neurotransmitter receptors that have been attributed to schizophrenia are connected to these pathways, for example, the presynaptic dopamine D3 receptor, the muscarinic acetylcholine receptor, the serotonergic receptor 5HT2. DNA sequence variants within the coding or regulatory sequences of the PIP5K2A gene may have impact on enzyme activity and interfere with phosphoinositide pathways, possibly inducing an enhanced risk for development of schizophrenia.
There are two types of PIPK involved in phosphoinositide signalling, type I kinases phosphorylate PI(4)P in the 5th position, whereas PIPKs from type II phosphorylate PI(5)P in the 4th position. These kinases have been shown to be differentially localized, and may participate in the synthesis of PI(4,5)P 2 at distinct sites.
39 PIP5K2A belongs to the type II kinases that have been found in cytosol, nucleus and associated with the endoplasmic reticulum. 39 The physiological role of type II kinases is not well defined yet, but they may be involved in tumour necrosis factor (TNF)a-mediated signalling. 66 Interestingly, there are some reports on association of SNPs in the TNFa gene with schizophrenia, 67, 68 suggesting that impairment of TNFa-mediated signalling may contribute to development of schizophrenia. Moreover, there are also reports on a possible involvement of PIP5K2A in the regulation of gene expression, pre-mRNA processing and mRNA transport in general. 40, 69, 70 Another function of type II kinases, that is, regulation of PI(5)P levels for synthesis of PI(3,4,5)P 3 , was recently discovered. 71 PI(3,4,5)P 3 is involved in the 72, 73 Additional support for a role of AKT pathways in schizophrenia comes from the use of lithium, valproic acid and carbamazepine as mood stabilizers in major psychoses. These drugs have been found to interfere with AKT-mediated pathways. 62 The tertiary structure of PIP5K2B located on chromosome 17q12, an isomer to PIP5K2A with approximately 78% homology, has been published. 74 There are highly conserved regions shared by the two isozymes, that is, the activation loop, the ATP binding sites and several sites forming a-helices. The sequence of a-helix 8 reads SKKNFLEKLKRDVEFLA for PIPK2B and NKKVFLEKLKRDVEFLA for PIP5K2A. 74 The coding variant SNP M41 leads to a non-synonymous exchange of N to S in the first position of the highly conserved a-helix 8 of PIP5K2A. Helix 8 does not seem to be directly involved in function, but the substitution of N with S, a possible target for phosphorylation, may influence the structure of the protein with consequences for function. The high frequency of the associated major allele (0.603 in nonaffected, 0.784 in affected; Table 1 ) as well as the relatively low attributable risk of 1.92 as estimated from the ratio transmitted to non-transmitted 60 would be compatible with the common disease/common allele hypothesis. 75, 76 However, the variant could also reflect LD with another, not yet identified risk conferring allele, rather than being a disease-causing susceptibility allele by itself. Studying the impact of the amino-acid exchange on enzyme activity, that is, enzymatic phosphorylation of PIP and correlation with the genotype, may help to clarify this question.
In addition to the Dutch study mentioned above, 65 this polymorphism was tested in another case-control sample comprising 176 patients with schizophrenia and 178 controls from North America with European background and from Israel, as well as in a sample comprising 198 bipolar patients and 212 controls from USA and the Czech Republic, 77 following up our preliminary report on association of the N251S polymorphism in schizophrenia at the IXth World Congress for Psychiatric Genetics 2001. 64 Association was not detected with this particular variant, but a modest difference was found in the distribution of alleles from the CT repeat pik53 þ 54 (M45), which was also associated in our sample (Table 1 , P = 0.026).
In conclusion, we have obtained evidence for association of schizophrenia with DNA sequence variants in the gene for the enzyme PIP5K2A, which is located in an area on chromosome 10p where several groups earlier reported linkage. We have identified a non-synonymous amino-acid exchange variant eventually interfering with functioning of phosphoinositide signalling pathways. Malfunctioning of these pathways might be a plausible mechanism participating in development of schizophrenia. The here reported association of DNA sequence variants in the PIP5K2A gene has been replicated in an additional, independent sample. However, before a role in ethiology of schizophrenia can be postulated, impact of the N251S amino-acid exchange variant on PIP5K2A activity has to be shown in future functional studies.
